Patents by Inventor Klaas Zwier

Klaas Zwier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIFEPRUNOX MESYLATE MAINTENANCE DOSE COMPOSITIONS AND METHODS FOR USING THE SAME
    Publication number: 20110200687
    Abstract: The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders.
    Type: Application
    Filed: March 8, 2011
    Publication date: August 18, 2011
    Inventors: Irene EIJGENDAAL, Gerrit Klein, Maria J.L. Terhorst-Van Amstel, Klaas ZWIER, Nico BRUINS, Hendrikus T. RIGTER, Erik GOUT, Caroline BOON, Michiel H. De Vries, Dorte MALLING, Anneke WINSEMIUS, Sangeeta RAJE, Ellen Bech CHRISTENSEN, Jeff PAUL
  • Bifeprunox mesylate maintenance dose compositions and methods for using the same
    Patent number: 7964604
    Abstract: The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: June 21, 2011
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria J. L. Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus T. Rigter, Erik Gout, Caroline Boon, Michiel H. De Vries, Dorte Malling, Anneke Winsemius, Sangeeta Raje, Ellen Bech Christensen, Jeff Paul
  • Bifeprunox mesylate maintenance dose compositions and methods for using the same
    Publication number: 20080286258
    Abstract: The present disclosure provides novel pharmaceutical dosage forms such as a maintenance treatment dose and methods for making the same, and methods for using said compounds and maintenance treatment doses to treat and prevent diseases and/or disorders.
    Type: Application
    Filed: March 23, 2007
    Publication date: November 20, 2008
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria J.L. Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus T. Rigter, Erik Gout, Caroline Boon, Michiel H. De Vries, Dorte Malling, Anneke Winsemius, Sangeeta Raje, Ellen Bech Christensen, Jeff Paul
  • Stable crystalline form of bifeprunox mesylate (7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
    Patent number: 7435738
    Abstract: The invention relates to a stable polymorphic form of the compound 7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2 (3H)-benzoxazolone monomethanesulfonate (INNM bifeprunox mesylate), a method for the preparation of said polymorphic form and its use in pharmaceutical products, especially in pharmaceutical products for the treatment of psychotic disorders and Parkinson's disease.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: October 14, 2008
    Assignee: Solvay Pharmaceuticals, Inc.
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria J. L. Terhorst-Van Amstel, Klaas Zwier
  • Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
    Patent number: 7423040
    Abstract: The present disclosure provides novel pharmaceutical compounds and methods for making the same, novel pharmaceutical dosage forms and methods for making the same, and methods for using said compounds and dosage forms to treat and prevent diseases and/or disorders.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: September 9, 2008
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria J. L. Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus T. Rigter, Erik Gout, Caroline Boon, Michiel H. De Vries
  • Stable crystalline form of bifeprunox mesylate (7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
    Patent number: 7405216
    Abstract: The invention relates to a stable polymorphic form of the compound 7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate (INNM bifeprunox mesylate), a method for the preparation of said polymorphic form and its use in pharmaceutical products, especially in pharmaceutical products for the treatment of psychotic disorders and Parkinson's disease.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: July 29, 2008
    Assignee: Solvay Pharmaceuticals, B.V.
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria J. L. Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus T. Rigter, Erik Gout
  • Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
    Publication number: 20060194812
    Abstract: The present disclosure provides novel pharmaceutical compounds and methods for making the same, novel pharmaceutical dosage forms and methods for making the same, and methods for using said compounds and dosage forms to treat and prevent diseases and/or disorders.
    Type: Application
    Filed: February 16, 2006
    Publication date: August 31, 2006
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus Rigter, Eric Gout, Caroline Boon, Michiel De Vries
  • Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
    Publication number: 20060040932
    Abstract: The invention relates to a stable polymorphic form of the compound 7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate (INNM bifeprunox mesylate), a method for the preparation of said polymorphic form and its use in pharmaceutical products, especially in pharmaceutical products for the treatment of psychotic disorders and Parkinson's disease.
    Type: Application
    Filed: August 18, 2004
    Publication date: February 23, 2006
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus Rigter, Erik Gout
  • Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
    Publication number: 20050107396
    Abstract: The invention relates to a stable polymorphic form of the compound 7-[4-([1,1?-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate (INNM bifeprunox mesylate), a method for the preparation of said polymorphic form and its use in pharmaceutical products, especially in pharmaceutical products for the treatment of psychotic disorders and Parkinson's disease.
    Type: Application
    Filed: August 18, 2004
    Publication date: May 19, 2005
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria Terhorst-Van Amstel, Klaas Zwier